Home » Topics » BioWorld Science

BioWorld Science
RSS

MedImmune initiates phase I study of MEDI-2228 in relapsed or refractory multiple myeloma

May 28, 2018

New phase I study evaluates MRX-2843 in patients with advanced or metastatic solid tumors

May 28, 2018

Roche presents compounds for HBV infection

May 28, 2018

Braeburn resubmits CAM-2038 NDA for opioid use disorder to FDA

May 28, 2018

Janssen Pharmaceutica discloses BACE1 and/or BACE2 inhibitors

May 28, 2018

Pfizer's Xeljanz approved for new indication in Japan

May 28, 2018

Janssen to terminate studies of daratumumab with atezolizumab and JNJ-63723283

May 28, 2018

Croma-Pharma identifies H2S-releasing compounds

May 28, 2018

Beactica extends master service agreement with Sanofi

May 28, 2018

Roche and Genentech disclose IRAK-4 inhibitors

May 28, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...